Results 121 to 130 of about 46,971 (258)

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impactResearch in context

EBioMedicine, 2019
Background: Pneumococcal conjugate vaccines have reduced the incidence of invasive pneumococcal disease, caused by vaccine serotypes, but non-vaccine-serotypes remain a concern.
Rebecca A. Gladstone, Stephanie W. Lo, John A. Lees, Nicholas J. Croucher, Andries J. van Tonder, Jukka Corander, Andrew J. Page, Pekka Marttinen, Leon J. Bentley, Theresa J. Ochoa, Pak Leung Ho, Mignon du Plessis, Jennifer E. Cornick, Brenda Kwambana-Adams, Rachel Benisty, Susan A. Nzenze, Shabir A. Madhi, Paulina A. Hawkins, Dean B. Everett, Martin Antonio, Ron Dagan, Keith P. Klugman, Anne von Gottberg, Lesley McGee, Robert F. Breiman, Stephen D. Bentley   +25 more
doaj  

Protein conjugate pneumococcal vaccines [PDF]

, 2002
Vana Spoulou
openalex   +2 more sources

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis

Health Technology Assessment
Background Vaccination of infants with pneumococcal conjugate vaccines is recommended by the World Health Organization. Evidence is mixed regarding the differences in immunogenicity and efficacy of the different pneumococcal vaccines.
Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian PT Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A Madhi, Kim Mulholland, Andrew J Pollard, Simon Procter, Beth Temple, Merryn Voysey   +13 more
doaj   +1 more source

Pneumococcal conjugate vaccine: From the petri dish to clinical practice [PDF]

, 2001
Joanne Embreé
openalex   +1 more source

Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae : herd immunity and reduction of otitis morbidity

, 2000
Ron Dagan, Drora Fraser
openalex   +1 more source

Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease [PDF]

The Lancet Infectious Diseases, 2021
Paulo Augusto Moreira Camargos, Cristiana M. Nascimento-Carvalho, Eliane de Freitas Drumond   +2 more
openaire   +2 more sources

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece. [PDF]

Front Public Health, 2023
Gourzoulidis G, Barmpouni M, Kossyvaki V, Vietri J, Tzanetakos C.   +4 more
europepmc   +1 more source

Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, and Shigella flexneri Type 2a Polysaccharides in Mice

, 2000
Danka Pavliakova, J. Scott Moncrief, David M. Lyerly, Gerald Schiffman, Dolores A. Bryla, John B. Robbins, Rachel Schneerson   +6 more
openalex   +1 more source

Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? [PDF]

, 2002
E. David G. McIntosh
openalex   +1 more source